This page shows the latest US market news and features for those working in and with pharma, biotech and healthcare.
It is a key step for the Servier Group as it will significantly strengthen our position in the US and reinforce our R&D capabilities in oncology. ... Aside from strengthening its oncology portfolio, Servier’s acquisition of Agios will allow the company
Bringing Zepzelca to the US market earlier this year alongside our partner, PharmaMar, was an important advance for adults with metastatic SCLC, an aggressive disease with a historically poor prognosis," said ... Jazz licensed lurbinectedin from
Researchers found that Venclyxto (venetoclax) – known as Venclexta in the US – in combination with azacitidine extended overall survival (OS) compared to the azacitidine plus placebo arm. ... 2020. AbbVie sells the drug on its own outside the US,
Our growth drivers and launches continue their strong momentum, with Cosentyx and Entresto increasing market share in the US.
CLL). Venclyxto (venetoclax) – known as Venclexta in the US – was co-developed by AbbVie and Roche and the combination with Gazyva (obinutuzumab) in frontline treatment of CLL could see its use ... AbbVie sells the drug on its own outside the US,
US pharma market. ... According to Reuters, around 88% of APIs used in drugs for the US market were manufactured overseas in 2018, with around 14% in that year produced in China.
More from news
Approximately 1 fully matching, plus 823 partially matching documents found.
Access to healthcare, including affordable medicines, remains a top concern across the US. ... As more biosimilars enter the US market, patients treated with biologic medicines will have access to a broader set of more affordable treatment options.
Yet unlike generic medicines, which have delivered substantial savings in the small molecule market, the success of biosimilars in the US has been mixed. ... Moreover, increasing the number of available biosimilars on the US market can improve access to
But for the most part, the feast-and-famine cycle of the US market has been viewed as a success. ... And finally there is the issue of interchangeability. In a move unique to the US market, the BPCI created two pathways for approval: an abbreviated one
The significance of the US market is also why Ehrlich, along with many others on the business/ marketing side of the industry, has little faith that importing cheaper drugs into the ... Drug-makers will not allow their golden goose US market to be
the US market when they would, de facto, be barred from other developed and price-controlled markets. ... It would have a disproportionate effect, for example, on companies who depend heavily on the US market.
More from intelligence
Approximately 0 fully matching, plus 52 partially matching documents found.
The new office in Cambridge, Massachusetts, will give ramarketing a presence in the growing pharma and biotech hub and a foothold in the US market, allowing it to locally service its ... Emma’s insight into the global life sciences sector means she
Prior to this, Jenkins spent 17 years at GlaxoSmithKline (GSK) in the UK and US. ... UK. Vu, whose new post will see him further expand Concept’s presence in the US market, joins the company with over 15 years’ experience in both business development
Joining the agency with twenty years’ biopharmaceutical industry experience, Jones’ expertise lies in market access, therapy launch and patient centric services. ... Creating a unique role within our field of expertise will enable us to offer a
Rita Glaze joins the firm as leader of value, pricing and market access practice. ... Joining the network from Edelman, Glaze previously led the design and implementation of its US market access communications offering.
With more than 20 years’ experience in the clinical development industry, Edwards joins the company after spending five years as vice president and general manager of the US operations for Exco ... expand the US market.”.
More from appointments
Approximately 1 fully matching, plus 25 partially matching documents found.
Lighthouse Medical Communications US (focusing on the US market) and Bluedog (digital and creative). ... Effective immediately, all teams delivering medical communications outside of the US will now fall under just one Lucid Group brand – aptly named,
Move builds on Envision’s established leadership position as the preferred tech-enabled scientific communications company for medical affairs, while deepening its presence in the critical US domestic market, and with ... With Envision’s global
About Us. Valid Insight is an award-winning, pharmaceutical, global market access consultancy. ... Pharmaceutical, medical device and biotechnology clients across the globe turn to us for consulting on healthcare market access and value communication
Global healthcare market research consultancy Research Partnership has appointed Jennifer Stewart as a Director in their US offices in Philadelphia. ... Jennifer is a seasoned market research professional with extensive experience in both custom research
Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up and we would love to work with you.
More from PMHub
Approximately 0 fully matching, plus 45 partially matching documents found.
Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...